MX2013004338A - Secuencias de repeticiones palindromicas cortas separadas regularmente agrupadas-cas (crisp-cas). - Google Patents

Secuencias de repeticiones palindromicas cortas separadas regularmente agrupadas-cas (crisp-cas).

Info

Publication number
MX2013004338A
MX2013004338A MX2013004338A MX2013004338A MX2013004338A MX 2013004338 A MX2013004338 A MX 2013004338A MX 2013004338 A MX2013004338 A MX 2013004338A MX 2013004338 A MX2013004338 A MX 2013004338A MX 2013004338 A MX2013004338 A MX 2013004338A
Authority
MX
Mexico
Prior art keywords
lactococcus crispr
cas sequences
lactococcus
crispr
cas
Prior art date
Application number
MX2013004338A
Other languages
English (en)
Inventor
Philippe Horvath
Dennis Romero
Anne M Millen
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Publication of MX2013004338A publication Critical patent/MX2013004338A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

La presente invención se refiere a un ácido nucleico que comprende una región de repetición de CRISPR de Lactococcus y/o una región separadora de CRISPR de Lactococcus.
MX2013004338A 2010-10-20 2011-10-20 Secuencias de repeticiones palindromicas cortas separadas regularmente agrupadas-cas (crisp-cas). MX2013004338A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39497610P 2010-10-20 2010-10-20
US40531710P 2010-10-21 2010-10-21
PCT/US2011/057102 WO2012054726A1 (en) 2010-10-20 2011-10-20 Lactococcus crispr-cas sequences

Publications (1)

Publication Number Publication Date
MX2013004338A true MX2013004338A (es) 2013-05-20

Family

ID=44863288

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004338A MX2013004338A (es) 2010-10-20 2011-10-20 Secuencias de repeticiones palindromicas cortas separadas regularmente agrupadas-cas (crisp-cas).

Country Status (11)

Country Link
US (1) US9951341B2 (es)
EP (1) EP2630156B1 (es)
CN (1) CN103261213A (es)
AU (1) AU2011316980A1 (es)
BR (1) BR112013009583A2 (es)
CA (1) CA2814810A1 (es)
DK (1) DK2630156T3 (es)
EA (1) EA201390586A1 (es)
MX (1) MX2013004338A (es)
NZ (1) NZ607870A (es)
WO (1) WO2012054726A1 (es)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2336362T3 (en) 2005-08-26 2019-01-21 Dupont Nutrition Biosci Aps USE OF CRISPR-ASSOCIATED GENES (CAS)
ES2590925T3 (es) 2006-05-19 2016-11-24 Dupont Nutrition Biosciences Aps Microorganismos marcados y métodos de marcado
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
GB201122458D0 (en) 2011-12-30 2012-02-08 Univ Wageningen Modified cascade ribonucleoproteins and uses thereof
GEP20217251B (en) 2012-05-25 2021-04-26 Charpentier Emmanuelle De Emanuel Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
KR102676910B1 (ko) 2012-12-06 2024-06-19 시그마-알드리치 컴퍼니., 엘엘씨 Crispr-기초된 유전체 변형과 조절
CN111454951A (zh) 2013-03-14 2020-07-28 卡里布生物科学公司 以核酸为靶的核酸的组合物和方法
EP3865586A1 (en) 2013-03-15 2021-08-18 The General Hospital Corporation Increasing specificity for rna-guided genome editing
US9234213B2 (en) 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
US10760064B2 (en) 2013-03-15 2020-09-01 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
WO2014204578A1 (en) 2013-06-21 2014-12-24 The General Hospital Corporation Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
CN115261411A (zh) 2013-04-04 2022-11-01 哈佛学院校长同事会 利用CRISPR/Cas***的基因组编辑的治疗性用途
US9902973B2 (en) 2013-04-11 2018-02-27 Caribou Biosciences, Inc. Methods of modifying a target nucleic acid with an argonaute
EP3019595A4 (en) 2013-07-09 2016-11-30 THERAPEUTIC USES OF A GENERIC CHANGE WITH CRISPR / CAS SYSTEMS
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
TW201542816A (zh) 2013-09-18 2015-11-16 Kymab Ltd 方法、細胞與生物體
US10584358B2 (en) * 2013-10-30 2020-03-10 North Carolina State University Compositions and methods related to a type-II CRISPR-Cas system in Lactobacillus buchneri
US10752906B2 (en) 2013-11-05 2020-08-25 President And Fellows Of Harvard College Precise microbiota engineering at the cellular level
PT3066201T (pt) 2013-11-07 2018-06-04 Massachusetts Inst Technology Métodos e composições relacionadas com crispr com arng reguladores
US11053481B2 (en) 2013-12-12 2021-07-06 President And Fellows Of Harvard College Fusions of Cas9 domains and nucleic acid-editing domains
US10787654B2 (en) 2014-01-24 2020-09-29 North Carolina State University Methods and compositions for sequence guiding Cas9 targeting
CA2943775A1 (en) 2014-03-25 2015-10-01 Ginkgo Bioworks, Inc. Methods and genetic systems for cell engineering
JP2017512481A (ja) 2014-04-08 2017-05-25 ノースカロライナ ステート ユニバーシティーＮｏｒｔｈ Ｃａｒｏｌｉｎａ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ Ｃｒｉｓｐｒ関連遺伝子を用いた、ｒｎａ依存性の転写抑制のための方法および組成物
AU2015298571B2 (en) 2014-07-30 2020-09-03 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
EP3633032A3 (en) 2014-08-28 2020-07-29 North Carolina State University Novel cas9 proteins and guiding features for dna targeting and genome editing
GB201506509D0 (en) 2015-04-16 2015-06-03 Univ Wageningen Nuclease-mediated genome editing
EP4233546A3 (en) * 2015-05-06 2023-09-27 SNIPR Technologies Limited Altering microbial populations & modifying microbiota
US10968426B2 (en) 2015-05-08 2021-04-06 President And Fellows Of Harvard College Universal donor stem cells and related methods
CN108026536A (zh) 2015-05-29 2018-05-11 北卡罗来纳州立大学 使用crispr核酸筛选细菌、古细菌、藻类和酵母的方法
KR20220158846A (ko) 2015-06-15 2022-12-01 노쓰 캐롤라이나 스테이트 유니버시티 핵산 및 rna-기반 항미생물제를 효율적으로 전달하기 위한 방법 및 조성물
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
US10648020B2 (en) 2015-06-18 2020-05-12 The Broad Institute, Inc. CRISPR enzymes and systems
US9512446B1 (en) 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
CA2996888A1 (en) 2015-08-28 2017-03-09 The General Hospital Corporation Engineered crispr-cas9 nucleases
US9926546B2 (en) 2015-08-28 2018-03-27 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
EP3356533A1 (en) 2015-09-28 2018-08-08 North Carolina State University Methods and compositions for sequence specific antimicrobials
JP7109784B2 (ja) 2015-10-23 2022-08-01 プレジデント アンド フェローズ オブ ハーバード カレッジ 遺伝子編集のための進化したＣａｓ９蛋白質
US11542466B2 (en) 2015-12-22 2023-01-03 North Carolina State University Methods and compositions for delivery of CRISPR based antimicrobials
DK3408382T3 (da) 2016-01-27 2022-06-20 Oncorus Inc Onkolytiske virale vektorer og anvendelser deraf
EP3219799A1 (en) 2016-03-17 2017-09-20 IMBA-Institut für Molekulare Biotechnologie GmbH Conditional crispr sgrna expression
EP3445853A1 (en) 2016-04-19 2019-02-27 The Broad Institute, Inc. Cpf1 complexes with reduced indel activity
US11078481B1 (en) 2016-08-03 2021-08-03 KSQ Therapeutics, Inc. Methods for screening for cancer targets
CN110214183A (zh) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 腺苷核碱基编辑器及其用途
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
US11078483B1 (en) 2016-09-02 2021-08-03 KSQ Therapeutics, Inc. Methods for measuring and improving CRISPR reagent function
SG11201903089RA (en) 2016-10-14 2019-05-30 Harvard College Aav delivery of nucleobase editors
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
JP2020510439A (ja) 2017-03-10 2020-04-09 プレジデント アンド フェローズ オブ ハーバード カレッジ シトシンからグアニンへの塩基編集因子
IL306092A (en) 2017-03-23 2023-11-01 Harvard College Nucleic base editors that include nucleic acid programmable DNA binding proteins
BR112019021719A2 (pt) 2017-04-21 2020-06-16 The General Hospital Corporation Variantes de cpf1 (cas12a) com especificidade para pam alterada
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
JP7324713B2 (ja) 2017-05-25 2023-08-10 ザ ジェネラル ホスピタル コーポレイション 改善された精度および特異性を有する塩基エディター
SG11202000691XA (en) 2017-07-26 2020-02-27 Oncorus Inc Oncolytic viral vectors and uses thereof
EP3658573A1 (en) 2017-07-28 2020-06-03 President and Fellows of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
EP3676376A2 (en) 2017-08-30 2020-07-08 President and Fellows of Harvard College High efficiency base editors comprising gam
CN111757937A (zh) 2017-10-16 2020-10-09 布罗德研究所股份有限公司 腺苷碱基编辑器的用途
EP3861120A4 (en) 2018-10-01 2023-08-16 North Carolina State University RECOMBINANT TYPE I CRISPR-CAS SYSTEM
US20220177943A1 (en) * 2018-10-01 2022-06-09 Rodolphe Barrangou Recombinant type i crispr-cas system and uses thereof for screening for variant cells
WO2020163396A1 (en) 2019-02-04 2020-08-13 The General Hospital Corporation Adenine dna base editor variants with reduced off-target rna editing
WO2020191241A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
CA3177481A1 (en) 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
CA3228506A1 (en) * 2021-08-12 2023-02-16 Anne M. Millen Compositions and methods for controlling adaptive immunity in bacteria
US20230279442A1 (en) 2021-12-15 2023-09-07 Versitech Limited Engineered cas9-nucleases and method of use thereof
CN115287244B (zh) * 2022-06-28 2023-07-25 北部湾大学 鱼源无乳链球菌internalin基因LRR结构域敲除突变株及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2225783A (en) 1939-04-07 1940-12-24 Lloyd B Jensen Sausage treatment
US3024116A (en) 1959-02-24 1962-03-06 Libby Mcneill And Libby Food processing
US3403032A (en) 1967-10-04 1968-09-24 Agriculture Usa Pure culture fermentation process for pickled cucumbers
US3897307A (en) 1974-10-23 1975-07-29 Hansens Lab Inc Stabilized dry cultures of lactic acid-producing bacteria
US3932674A (en) 1974-11-29 1976-01-13 The United States Of America Controlled bulk vegetable fermentation
US4140800A (en) 1977-06-13 1979-02-20 Leo Kline Freeze-dried natural sour dough starter
US4423079A (en) 1980-07-14 1983-12-27 Leo Kline Growth promoting compositions for Lactobacillus sanfrancisco and method of preparation
US4621058A (en) 1983-04-11 1986-11-04 Mid-America Dairymen, Inc. Method of preparing cheese starter media
NZ239639A (en) 1990-09-05 1993-05-26 Univ North Carolina State Phage resistant fermentations using a bacterial culture of isogenic strains carrying different phage defense mechanisms
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US7919277B2 (en) * 2004-04-28 2011-04-05 Danisco A/S Detection and typing of bacterial strains
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
DK2336362T3 (en) 2005-08-26 2019-01-21 Dupont Nutrition Biosci Aps USE OF CRISPR-ASSOCIATED GENES (CAS)
ES2590925T3 (es) 2006-05-19 2016-11-24 Dupont Nutrition Biosciences Aps Microorganismos marcados y métodos de marcado
MX2009009071A (es) 2007-03-02 2009-09-24 Danisco Cultivos con resistencia mejorada a fagos.
DK2362915T3 (en) * 2008-11-07 2017-03-27 Dupont Nutrition Biosci Aps CRISPR SEQUENCES OF BIFIDOBACTERIA

Also Published As

Publication number Publication date
CN103261213A (zh) 2013-08-21
EP2630156A1 (en) 2013-08-28
US9951341B2 (en) 2018-04-24
US20130288251A1 (en) 2013-10-31
WO2012054726A1 (en) 2012-04-26
AU2011316980A1 (en) 2013-04-18
BR112013009583A2 (pt) 2017-05-30
EP2630156B1 (en) 2018-08-22
NZ607870A (en) 2015-09-25
CA2814810A1 (en) 2012-04-26
EA201390586A1 (ru) 2014-11-28
DK2630156T3 (en) 2018-12-17

Similar Documents

Publication Publication Date Title
MX2013004338A (es) Secuencias de repeticiones palindromicas cortas separadas regularmente agrupadas-cas (crisp-cas).
HK1212376A1 (en) Rna-guided human genome engineering rna
HK1217967A1 (zh) 多重 引導基因組工程
MX2012007710A (es) Alfa-amilasas.
SG11201503646TA (en) Esterification of 2,5-furan-dicarboxylic acid
PT2922554T (pt) Arn modificado nas porções terminais
EP2539913A4 (en) PHOSPHORESCENT EMITTERS
MX2013001045A (es) Organoide hepatico, sus usos y metodo de cultivo para obtenerlos.
EP2558999A4 (en) SOCIAL NETWORK HOMEPAGE
GB201106792D0 (en) .
GB201104434D0 (en) .
EP2647644A4 (en) RNA MODIFIED BY 2'-O
SG10201802883UA (en) Nucleic acid amplification
EP2526185A4 (en) BACTERIUM WITH REGULATED RFAH NUCLEIC ACID
GB201106766D0 (en) .
ZA201209473B (en) Direct smelting process
GB201219989D0 (en) Bacterial engineering
PL2616562T3 (pl) Bezpośredni sposób wytapiania
HUE041320T2 (hu) 1,3-Specifikus intraészterezés
MX2012010317A (es) ß-HIDROXIALQUILAMIDAS, METODO PARA SU PRODUCCION Y SU USO.
EP2820116A4 (en) NUCLEINSÄUREAMPLIFIKATIONSREAKTOR
GB201012359D0 (en) Invention 6.5.10
GB201104430D0 (en) .
WO2014093305A3 (en) Micrornas and uses thereof
EP2544534A4 (en) COMPOSITIONS, METHODS AND DEVICES USED IN THE TREATMENT OF DYSMENORRHEA